UCLE · As filed with the SEC
US Nuclear income statement, by quarter
The statement as US Nuclear presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Condensed Consolidated Statements of Operations (Unaudited) · USD
| USD | Q1 2026 3 months ended Mar 31, 2026 | Q4 2025 3 months ended Dec 31, 2025 | Q3 2025 3 months ended Sep 30, 2025 | Q2 2025 3 months ended Jun 30, 2025 |
|---|---|---|---|---|
| Sales | 352,209 | — | 595,305 | 447,071 |
| Cost of sales | 197,214 | — | 296,163 | 197,739 |
| Gross profit | 154,995 | — | 299,142 | 249,332 |
| Operating expenses | ||||
| Selling, general and administrative expenses | 300,898 | — | 557,518 | 405,457 |
| Total operating expenses | 300,898 | — | 557,518 | 405,457 |
| Loss from operations | (145,903) | — | (258,376) | (156,125) |
| Other income (expense) | ||||
| Interest expense | (41,183) | — | (69,269) | (27,674) |
| Incentive expense | — | — | — | (24,000) |
| Other income | 0 | — | 475,000 | — |
| Total other income (expense) | (41,183) | — | 405,731 | (51,674) |
| Loss before provision for income taxes | (187,086) | — | 147,355 | (207,799) |
| Net loss | (187,086) | — | 147,355 | (207,799) |
| Preferred stock dividends | (88,019) | — | (52,509) | (46,032) |
| Net loss attributed to common stockholders | (275,105) | — | 94,846 | (253,831) |
| Weighted average shares outstanding - basic (in Shares) | 62,701,458 | — | 63,535,458 | 47,913,673 |
| Weighted average shares outstanding - diluted (in Shares) | 62,701,458 | — | 63,535,458 | 47,913,673 |
| Loss per shares - basic (in Dollars per share) | 0 | — | 0 | (0.01) |
| Loss per shares - diluted (in Dollars per share) | 0 | — | 0 | (0.01) |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.